Medline, Formerly Reported as Medline Industries, LP

Medical product manufacturing and distribution

Based in IL

🤖

AI Overview

With $6.0M in lobbying spend across 21 quarterly filings, Medline, Formerly Reported as Medline Industries, LP is one of the biggest lobbying spenders in Washington. Their lobbying covers 7 issue areas. Active from 2021 to 2025.

$6.0M
Total Spend
5
Years Active
1
Firms Hired
2
Lobbyists Deployed
7
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$980K
2022$1.1M
2023$1.1M
2024$1.1M
2025$1.9M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Medline, Formerly Reported as Medline Industries, LP disclosed contacting in their lobbying filings.

Environmental Protection Agency (EPA)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEState, Dept of (DOS)Food & Drug Administration (FDA)White House OfficeU.S. Trade Representative (USTR)Commerce, Dept of (DOC)Office of Management & Budget (OMB)Small Business Administration (SBA)Homeland Security, Dept of (DHS)Natl Economic Council (NEC)Natl Security Council (NSC)Intl Trade Administration (ITA)Defense, Dept of (DOD)Treasury, Dept ofVeterans Affairs, Dept of (VA)Council of Economic Advisers (CEA)Bureau of Industry and Security (BIS)+1 more
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Environment, Tariffs, Trade, Manufacturing and 2 more

Health care supply chain and resiliency, S.308 - PPE in America Act regarding strategic national stockpile, H.R.346 - SUPPLIES Act regarding domestic medical supply production

Medical device sterilization, H.R.1512 - CLEAN Future Act regarding monitoring

Section 301 tariffs, S.1260 - United States Innovation and Competition Act of 2021 regarding Section 301 tariffs

Health care supply chain and resiliency

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.